Jonathan McNeill sold $370k of CBIO
President and COO at GLYCOMIMETICS INC. 20,549 shares at an average of $17.99, traded Jun 22, 2026, filed Jun 23, 2026.
Score components
- +20RolePresident
- +15Trade size$370k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster7 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-044885, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -20,549 | $17.99 | $370k | 139,158 | Jun 23, 2026 |
Related signals
Other insiders at GLYCOMIMETICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | GLYCOMIMETICS INC | Barbara Harlin Bispham See Remarks | $11k 620 shares | -3% | |
| 31Weak | GLYCOMIMETICS INC | Joshua T Brumm Chief Executive Officer | $160k 9,447 shares | -3% | |
| 23Weak | GLYCOMIMETICS INC | Jonathan McNeill President and COO | $77k 4,570 shares | -3% | |
| 17Weak | GLYCOMIMETICS INC | Richard William Scalzo Chief Financial Officer | $10k 568 shares | -3% | |
| 10Weak | GLYCOMIMETICS INC | Ellie Eunkyung Im Chief Medical Officer | $11k 623 shares | -3% | |
| 10Weak | GLYCOMIMETICS INC | Jan Pinkas Chief Scientific Officer | $12k 658 shares | -3% | |
| 10Weak | GLYCOMIMETICS INC | Ryan Lynch See Remarks | $4,296 240 shares | -2% | |
| 54Moderate | CBIObuy GLYCOMIMETICS INC | Fairmount Funds Management LLC director, owner | $12M 853,450 shares | +31% | |
| 10Weak | GLYCOMIMETICS INC | Barbara Harlin Bispham See Remarks | $22k 1,218 shares | -6% | |
| 47Moderate | GLYCOMIMETICS INC | Joshua T Brumm Chief Executive Officer | $761k 42,305 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.